1,361 results on '"Xu Jiake"'
Search Results
202. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database
203. Rosuvastatin Nanomicelles Target Neuroinflammation and Improve Neurological Deficit in a Mouse Model of Intracerebral Hemorrhage
204. The molecular structure and role of CCL2 (MCP‐1) and C‐C chemokine receptor CCR2 in skeletal biology and diseases
205. SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation
206. Donkey genomes provide new insights into domestication and selection for coat color
207. Three-dimensional ordered macropore structural TiO2 modified with Ni as photocatalysts
208. Molecular structure, gene expression and functional role of WFDC1 in angiogenesis and cancer
209. Osteoimmunological insights into the pathogenesis of ankylosing spondylitis
210. Systemic Administration of Fibroblast Growth Factor 21 Improves the Recovery of Spinal Cord Injury (SCI) in Rats and Attenuates SCI-Induced Autophagy
211. Osteoblast-derived EGFL6 couples angiogenesis to osteogenesis during bone repair
212. Codelivery of epigallocatechin-3-gallate and diallyl trisulfide by near-infrared light-responsive mesoporous polydopamine nanoparticles for enhanced antitumor efficacy
213. Targeted treatment for osteoarthritis: drugs and delivery system
214. Highly active g-C3N4 photocatalysts modified with transition metal cobalt for hydrogen evolution
215. STAT3 and its targeting inhibitors in osteosarcoma
216. Circular RNAs in childhood‐related diseases and cancers: A review
217. Highly Selective Gas Sensor Based on Hydrophobic Silica Decorated with Trimethoxyoctadecylsilane
218. Elastin fibers display a versatile microfibril network in articular cartilage depending on the mechanical microenvironments
219. New Insights Into the Role of Sequestosome 1/p62 Mutant Proteins in the Pathogenesis of Pagetʼs Disease of Bone
220. Divergent Effects of Endogenous and Exogenous Glucocorticoid-Induced Leucine Zipper in Animal Models of Inflammation and Arthritis
221. Hydrogen evolution performance of Ni loading on the carbon-based catalysts
222. Molecular structure, expression, and the emerging role of Siglec‐15 in skeletal biology and cancer.
223. Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL‐induced intracellular signaling pathways.
224. Introduction: Understanding the signalling mechanisms in molecular physiology and diseases
225. The molecular structure and function of sorting nexin 10 in skeletal disorders, cancers, and other pathological conditions
226. PEGylation of Deferoxamine for Improving the Stability, Cytotoxicity, and Iron-Overload in an Experimental Stroke Model in Rats
227. A missense mutation sheds light on a novel structure–function relationship of RANKL
228. Maackiain dampens osteoclastogenesis via attenuating RANKL‐stimulated NF‐κB signalling pathway and NFATc1 activity
229. Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
230. Inhibitory effects of biochanin A on titanium particle‐induced osteoclast activation and inflammatory bone resorption via NF‐κB and MAPK pathways
231. Alternative splicing of leptin receptor overlapping transcript in osteosarcoma
232. Carnosol suppresses RANKL‐induced osteoclastogenesis and attenuates titanium particles‐induced osteolysis
233. The Hippo in the room: Targeting the Hippo signalling pathway for osteosarcoma therapies
234. Injectable Gelatin Hydrogel Suppresses Inflammation and Enhances Functional Recovery in a Mouse Model of Intracerebral Hemorrhage
235. Betulinic Acid Protects From Bone Loss in Ovariectomized Mice and Suppresses RANKL-Associated Osteoclastogenesis by Inhibiting the MAPK and NFATc1 Pathways
236. Cytoplasmic PCNA is located in the actin belt and involved in osteoclast differentiation
237. The role of glial cell line‐derived neurotrophic factor family member artemin in neurological disorders and cancers
238. Molecular structure and function of microfibrillar‐associated proteins in skeletal and metabolic disorders and cancers
239. Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast Function
240. An emerging role of Prevotella histicola on estrogen-deficiency induced bone loss through the gut microbiota-bone axis
241. Hymenialdisine: A Marine Natural Product That Acts on Both Osteoblasts and Osteoclasts and Prevents Estrogen‐Dependent Bone Loss in Mice
242. Jatrophane Diterpenoids from Euphorbia esula as Inhibitors of RANKL-Induced Osteoclastogenesis
243. Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
244. Characterisation of genetic regulatory effects for osteoporosis risk variants in human osteoclasts
245. Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways
246. Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption
247. Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL‐stimulated NFATc1 activity
248. The repair and autophagy mechanisms of hypoxia-regulated bFGF-modified primary embryonic neural stem cells in spinal cord injury
249. Ellagic acid protects ovariectomy‐induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption
250. Molecular structure, expression, and functional role of Clec11a in skeletal biology and cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.